3 ms·
Currently in Phase 2 Clinical Development since Dec 2018, with interim data expected mid-2020 [1]. [1] https://valneva.com/wp-content/uploads/2019/06/2018_12_1
by wgjordan 7y ago
Currently in Phase 2 Clinical Development since Dec 2018, with interim data expected mid-2020 [1].
[1] https://valneva.com/wp-content/uploads/2019/06/2018_12_17_VLA_Lyme_Phase2_Initiation_PR_EN.pdf https://valneva.com/wp-content/uploads/2019/06/2018_12_17_VL...
- toomuchtodo 7y agoClincialtrials.gov tracking at https://clinicaltrials.gov/ct2/show/NCT03769194 https://clinicaltrials.gov/ct2/show/NCT03769194